AIM ImmunoTech And 3 Other Stocks Under $3 Insiders Are Buying
Portfolio Pulse from Avi Kapoor
Insiders at AIM ImmunoTech, Citizens, Inc., Power Solutions International, and Brightcove have recently made significant stock purchases. These transactions indicate insider confidence in the companies' prospects. Notably, these stocks are priced under $3, attracting attention from investors interested in penny stocks. Each company has had recent developments, such as executive appointments and financial results announcements, which could influence investor perception and stock performance.
March 25, 2024 | 10:33 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Brightcove's 10% owner Brolin Jonathan acquired 30,000 shares at $1.88 each, after the company issued FY24 guidance below estimates.
Despite issuing FY24 guidance below estimates, the significant insider purchase could indicate a belief in the company's long-term value, potentially stabilizing the stock.
CONFIDENCE 60
IMPORTANCE 60
RELEVANCE 75
POSITIVE IMPACT
AIM ImmunoTech's Director Nancy Bryan purchased 38,462 shares at $0.39 each. This follows the company's announcement of Phase 2 study results for a post-COVID treatment.
The insider purchase combined with recent positive study results could indicate a bullish outlook for AIM ImmunoTech, potentially leading to short-term stock appreciation.
CONFIDENCE 75
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Citizens, Inc.'s President and CEO Gerald Shields acquired 17,466 shares at $2.26 each, following the appointment of Jon Stenberg as President.
The CEO's stock purchase, especially after a significant leadership appointment, suggests confidence in the company's future, potentially leading to positive stock movement.
CONFIDENCE 70
IMPORTANCE 70
RELEVANCE 85
POSITIVE IMPACT
Power Solutions International's 10% owner Neil Gagnon bought 5,392 shares at $2.00 each, following the announcement of Q4 and full year 2023 financial results.
The insider purchase post-financial results announcement may reflect a positive outlook on the company's financial health and future prospects, potentially boosting stock price.
CONFIDENCE 65
IMPORTANCE 65
RELEVANCE 80